INTRODUCTION
Parkinson’s disease, PD
Oral carbidopa/levodopa (CD/LD) is the cornerstone of Parkinson’s disease (PD) treatment [Apomorphine, a D1-family and D2-family agonist with an affinity similar to dopamine, is used for the treatment of OFF episodes in patients with PD [SC-APO is a reliable, effective treatment option for managing OFF episodes; however, its utilization has been limited. SC-APO is administered by subcutaneous injection and involves a multistep product assembly for administration, which may be challenging for patients experiencing decreased motor function [